Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin

被引:268
作者
Cavalli, R [1 ]
Gasco, MR
Chetoni, P
Burgalassi, S
Saettone, MF
机构
[1] Univ Turin, Dipartimento Sci & Tecnol & Farm, I-10125 Turin, Italy
[2] Univ Pisa, Dipartimento Chim Bioorgan & Biofarm, I-56126 Pisa, Italy
关键词
solid lipid nanoparticles; SLN; tobramycin; rabbits; preocular retention; ocular delivery; aqueous humour bioavailability;
D O I
10.1016/S0378-5173(02)00080-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aim of this study was to evaluate solid lipid nanoparticles (SLN) as carriers for topical ocular delivery of tobramycin JOB). The SLN were in the colloidal size range (average diameter below 100 nm; polydispersity index below 0.2) and contained 2.5% TOB as ion-pair complex with hexadecyl phosphate. The preocular retention of SLN in rabbit eyes was tested using drug-free, fluorescent SLN (F-SLN): these were retained for longer times on the corneal surface and in the conjunctival sac when compared with an aqueous fluorescent solution. A suspension of TOB-loaded SLN (TOB-SLN) containing 0.3% w/v TOB was administered topically to rabbits, and the aqueous humour concentration of TOB was determined up to six hours. When compared with an equal dose of TOB administered by standard commercial eyedrops, TOB-SLN produced a significantly higher TOB bioavailability in the aqueous humour. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:241 / 245
页数:5
相关论文
共 18 条
  • [1] [Anonymous], ACTA TECHNOL LEGIS M
  • [2] ASSIL KK, 1991, INVEST OPHTH VIS SCI, V32, P3216
  • [3] Transmucosal transport of tobramycin incorporated in solid lipid nanoparticles (SLN) after duodenal administration to rats.: Part II -: Tissue distribution
    Bargoni, A
    Cavalli, R
    Zara, GP
    Fundarò, A
    Caputo, O
    Gasco, MR
    [J]. PHARMACOLOGICAL RESEARCH, 2001, 43 (05) : 497 - 502
  • [4] BOTTARI F, 1978, IL FARMACO ED PRATIC, V10, P434
  • [5] PREPARATION AND EVALUATION IN-VITRO OF COLLOIDAL LIPOSPHERES CONTAINING PILOCARPINE AS ION-PAIR
    CAVALLI, R
    MOREL, S
    GASCO, MR
    CHETONI, P
    SAETTONE, MF
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 117 (02) : 243 - 246
  • [6] Transmucosal transport of tobramycin incorporated in SLN after duodenal administration to rats.: Part I -: A pharmacokinetic study
    Cavalli, R
    Zara, GP
    Caputo, O
    Bargoni, A
    Fundarò, A
    Gasco, MR
    [J]. PHARMACOLOGICAL RESEARCH, 2000, 42 (06) : 541 - 545
  • [7] LONG-ACTING INJECTABLE OXYTETRACYCLINE-LIPOSPHERE FORMULATIONS
    DOMB, AJ
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 124 (02) : 271 - 278
  • [8] ELLIS PP, 1988, OPHTHALMIC SURG LAS, V19, P501
  • [9] FIBRIN-ENMESHED TOBRAMYCIN LIPOSOMES - SINGLE APPLICATION TOPICAL THERAPY OF PSEUDOMONAS KERATITIS
    FRUCHTPERRY, J
    ASSIL, KK
    ZIEGLER, E
    DOUGLAS, H
    BROWN, SI
    SCHANZLIN, DJ
    WEINREB, RN
    [J]. CORNEA, 1992, 11 (05) : 393 - 397
  • [10] TOBRAMYCIN LEVELS IN HUMAN EYES
    FURGIUELE, FP
    SMITH, JP
    BARON, JG
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1978, 85 (01) : 121 - 123